Effects of Health Care Provider-mediated, Remote Coaching System Through the PDA-type Glucometer and the Internet on Diabetes Management
1 other identifier
interventional
115
1 country
1
Brief Summary
The purpose of this study is to investigate the effectiveness of the new diabetes care delivery system applied to preexisting public health care resources through advanced information technologies such as PDA-type glucometer and the Internet on the glycemic control of type 2 diabetes patients lived in isolated rural area. The investigators conducted a prospective, randomized, controlled trial in patients with type 2 diabetes for 12 weeks. The intervention group was treated with the new health care delivery system, where diabetes center provided specialized management, mediated by nurse of primary health care posts using the Internet and the PDA-type glucometer, while the control group with conventional health care. HbA1c, fasting plasma glucose and lipids levels were measured at baseline and follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2009
CompletedFirst Posted
Study publicly available on registry
December 31, 2009
CompletedDecember 31, 2009
June 1, 2005
December 30, 2009
December 30, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HbA1c
Secondary Outcomes (1)
PP2hr Lipid profile
Study Arms (1)
Lifestyle counseling
EXPERIMENTALInterventions
supporting diabetes patients using Internet communication
Eligibility Criteria
You may qualify if:
- Type 2 diabetes patients
- Aged ≥ 40 years
- Baseline HbA1c of 7.0 to 11.0 % who had been already followed up for more than 6 months in the health care post
You may not qualify if:
- Participants with diagnosed or suspected disease of the liver, pancreas, endocrine organs, or kidney
- Ischemic heart disease or cerebrovascular disease or a history of such disease
- A creatinine level \> 0.133 mmol/L
- Treatment with an intensified insulin regimens and those unable .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul St. Mary's Hospital
Seoul, 137-041, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kun-Ho Yoon, Ph.D.
Catholic Medical College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Purpose
- SUPPORTIVE CARE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 30, 2009
First Posted
December 31, 2009
Last Updated
December 31, 2009
Record last verified: 2005-06